Beam Therapeutics Inc. (BMV:BEAM)

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $8.47M USD in the quarter ending June 30, 2025, a decrease of -28.08%. This brings the company's revenue in the last twelve months to $60.27M, down -82.90% year-over-year. In the year 2024, Beam Therapeutics had annual revenue of $63.52M, down -83.18%.

• Revenue (ttm): $60.27M
• Revenue Growth: -82.90%
• P/S Ratio: 40.14
• Revenue / Employee: $124.79K
• Employees: 483
• Market Cap: 45.62B MXN

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	63.52M	-314.19M	-83.18%
Dec 31, 2023	377.71M	316.79M	520.01%
Dec 31, 2022	60.92M	9.08M	17.51%
Dec 31, 2021	51.84M	51.82M	215,916.67%
Dec 31, 2020	24.00K	6.00K	33.33%